Corbus Pharmaceuticals
CRBP
$38.77
Share price
1.49%
Change (1 day)
344.61%
Change (1 year)
Categories
Corbus Pharmaceuticals (CRBP) - Total assets
Total assets on the balance sheet as of December 2023 : $28.27 M
According to Corbus Pharmaceuticals 's latest financial reports the company's total assets are $28.27 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Corbus Pharmaceuticals - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $28.27 M | -57.36% |
| 2022-12-31 | $66.31 M | -38.45% |
| 2021-12-31 | $0.10 B | 5.31% |
| 2020-12-31 | $0.10 B | 108.16% |
| 2019-12-31 | $49.14 M | 4.58% |
| 2018-12-31 | $46.98 M | -29.84% |
| 2017-12-31 | $66.97 M | 274.43% |
| 2016-12-31 | $17.88 M | 38.93% |
| 2015-12-31 | $12.87 M | 95.06% |
| 2014-12-31 | $6.6 M | 2060.5% |
| 2013-12-31 | $0.3 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | $0.96 B | 3,322.13% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | $0.64 B | 2,193.54% | 🇺🇸 USA |
 Epizyme EPZM | N/A | N/A | 🇺🇸 USA |
 Advaxis ADXS | $16.57 M | -41.36% | 🇺🇸 USA |